Home  /  Resource Library  /  Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database

Pharmacovigilance study for the identification of mogamulizumab-induced immune-related adverse events using a real-world database

Results of a pharmacovigilance study of mogamulizumab for treatment of CTCL.